Newborns Show Elevated Alzheimer's Biomarker Levels

A study found that newborns and Alzheimer's patients both have elevated levels of the biomarker p-tau217, but in newborns, this protein supports healthy brain development, whereas in Alzheimer's it is associated with disease progression. The findings suggest potential pathways for new treatments by understanding how the healthy brain regulates tau protein.